Cost of cabozantinib

cost of treatment. There was also uncertainty about which medicines The list price for cabozantinib is £5,143.-tab pack

by T Liu 2024Results. The estimated cost for nivolumab plus cabozantinib group was 654 851.32 USD, which was higher than 312 360.47 USD estimated for cabozantinib alone

Results: The total cost per patient was $681,425 for nivolumab plus cabozantinib and $256,302 for sunitinib. The incremental QALY for nivolumab plus cabozantinib was 0.49 compared with sunitinib. The ICER for nivolumab plus cabozantinib was $863,720 per QALY gained versus sunitinib.

Cabozantinib was found to be cost-effective for advanced RCC patients after failure of prior therapy at a 2 GDP threshold. Future research that costs less than the estimated population EVPI would be worth considering for a comparison of cabozantinib and nivolumab.

by C McCrea 2024 Cited by 27related to costs (cost year, 2024) were disease manage- ment costs with nivolumab and cabozantinib in mind. This analysis may be extended to an

by T Liu 2024The estimated cost for nivolumab plus cabozantinib group was 654 851.32 USD, which was higher than 312 360.47 USD estimated for cabozantinib alone group

The total mean incremental cost of cabozantinib was US$76,406 per patient. The incremental cost-effectiveness ratio for cabozantinib compared with best

The estimated cost for nivolumab plus cabozantinib group was 654 851.32 USD, which was higher than 312 360.47 USD estimated for cabozantinib alone group, resulting in an incremental cost (IC) of 342 490.85 USD.

How much does Cabozantinib cost? Cabozantinib, sold under the brand names Cometriq and Cabometyx, is an anti-cancer medication used to treat medullary